The diurnal rhythm of the cytoprotective human trefoil protein TFF2 is reduced by factors associated with gastric mucosal damage: Ageing, Helicobacter pylori Infection, and sleep deprivation

American Journal of Gastroenterology

Volumn 100, Issue 7, 2005, Pages 1491-1497

  Johns, C Emma ^a,d   Newton, Julia L ^b,c   Westley, Bruce R ^a,b   May, Felicity E B ^a,b,c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TREFOIL FACTOR 2; TREFOIL PEPTIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; CELL PROTECTION; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; GASTROINTESTINAL MUCOSA; GASTROINTESTINAL SYMPTOM; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MORBIDITY; NASOGASTRIC TUBE; NIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SEROLOGY; SLEEP DEPRIVATION; STOMACH JUICE; STOMACH MUCOSA LESION; UREA BREATH TEST; WESTERN TRANSFER ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; CIRCADIAN RHYTHM; CYTOPROTECTION; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MIDDLE AGED; MUCINS; MUSCLE PROTEINS; PEPTIDES; SLEEP;

EID: 22744448879     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.41859.x     Document Type: Article

References (34)

1. Allen A, Flemstrom G. Gastroduodenal mucus bicarbonate barrier: Protection against acid and pepsin. Am J Physiol Cell Physiol 2005;288:C1-C19.
2. Blaser MJ. The role of Helicobacter pylori in gastritis and its progression to peptic ulcer disease. Aliment Pharmacol Ther 1995;9:27-30.
3. Rockall T, Logan RFA, Devlin HB. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. BMJ 1995;311:222-6.
4. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984;i:1311-1315.
5. Hazell SL, Lee A, Brady L, Hennessy W. Campylobacter pylori dis and gastritis: Association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium. J Infect Dis 1986;153:658-63.
6. Odenbreit S, Puls J, Sedlmaier B, et al. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 2000;287:1497-500.
7. Rieder G, Hatz RA, Moran AP, et al. Role of adherence in interleukin-8 induction in Helicobacter pylori-associated gastritis. Infect Immun 1997;65:3622-30.
8. Kay L. Prevalence, incidence and prognosis of gastrointestinal symptoms in a random sample of an elderly population. Age Ageing 1994;94:146-9.
9. Poulsom R, Wright NA. Trefoil peptides: A newly recognized family of epithelial mucin-associated molecules. Am J Physiol 1993;265:G205-13.
10. May FEB, Westley BR. Trefoil proteins: Their role in normal and malignant cells. J Pathol 1997;183:4-7.
11. Thim L. Trefoil peptides: From structure to function. Cell Mol Life Sci 1997;53:888-903.
12. Taupin D, Podolsky DK. Trefoil factors: Initiators of mucosal healing. Nat Rev Mol Cell Biol 2003;4:721-32.
13. Lefebvre O, Chenard MP, Masson R, et al. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 1996;274:259-62.
14. Newton JL, Allen A, Westley BR, et al. The human trefoil peptide, TFF1, is present in different molecular forms that are intimately associated with mucus in normal stomach. Gut 2000;46:312-20.
15. Ruchaud-Sparagano MH, Westley BR, May FEB. The trefoil protein TFF1 is bound to MUC5AC in human gastric mucosa. Cell Mol Life Sci 2004;61:1946-54.
16. Marchbank T, Westley BR, May FEB, et al. Dimerization of human pS2 (TFF1) plays a key role in its protective/healing effects. J Pathol 1998;185:153-8.
17. Prest SJ, May FEB, Westley BR. The estrogen-regulated protein, TFF1, stimulates migration of human breast cancer cells. FASEB J 2002;16:592-4.
18. Playford RJ, Marchbank T, Chinery R, et al. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology 1995;108:108-16.
19. Dignass AU, Lynch-Devaney K, Kindon H, et al. Trefoil peptides promote epithelial migration through a transforming growth factor β-independent pathway. J Clin Invest 1994;94:376-83.
20. Playford RJ, Marchbank T, Goodlad RA, et al. Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc Natl Acad Sci USA 1996;93:2137-42.
21. Farrell JJ, Taupin D, Koh TJ, et al. TFF2/SP-deficient mice show decreased gastric proliferation, increased acid secretion, and increased susceptibility to NSAID injury. J Clin Invest 2002;109:193-204.
22. Alison MR, Chinery R, Poulsom R, et al. Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor, and transforming growth factor alpha mRNAs in rat stomach. J Pathol 1995;175:405-14.
23. May FEB, Semple JI, Newton JL, et al. The human two domain trefoil protein, TFF2, is glycosylated in vivo in the stomach. Gut 2000;46:454-9.
24. Semple JI, Newton JL, Westley BR, et al. Dramatic diurnal variation in the concentration of the human trefoil peptide TFF2 in gastric juice. Gut 2001;48:648-55.
25. Svanes C, Sothern RB, Sørbye H. Rhythmic patterns in incidence of peptic ulcer perforation over 5.5 decades in Norway. Chronobiol Int 1998;15:241-64.
26. Baron JH. History, methodology and interpretation. Clinical tests of gastric secretion. London: Macmillan, 1978.
27. Chadwick MP, Westley BR, May FEB. Homodimerization and hetero-oligomerization of the single-domain trefoil protein pNR-2/pS2 through cysteine 58. Biochem J 1997;327:117-23.
28. Clyne M, Dillon P, Daly S, et al. Helicobacter pylori interacts with the human single-domain trefoil protein TFF1. Proc Natl Acad Sci USA 2004;101:7409-14.
29. Longman RJ, Douthwaite J, Sylvester PA, et al. Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa. Gut 2000;47:792-800.
30. Gajhede M, Petersen TN, Henriksen A, et al. Pancreatic spasmolytic polypeptide: First three-dimensional structure of a member of the mammalian trefoil family of peptides. Structure 1993;1:253-62.
31. Williams MA, Westley BR, May FEB, et al. The solution structure of the disulphide-linked homodimer of the human trefoil protein TFF1. Pancreatic spasmolytic polypeptide: First three-dimensional structure of a member of the mammalian trefoil family of peptides. FEBS Lett 2001;493:70-4.
32. Muskett FW, May FEB, Westley BR, et al. Solution structure of the disulfide-linked dimer of human intestinal trefoil factor (TFF3): The intermolecular orientation and interactions are markedly different from those of other dimeric trefoil proteins. Biochemistry 2003;42:15139-47.
33. Somerville K, Faulkner G, Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986;1(8479):462-4.
34. Newton JL, Johns CE, May FEB. Review article: The ageing bowel and intolerance to aspirin. Aliment Pharmacol Ther 2004;19:39-45.